Literature DB >> 7528647

Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries.

F Cosentino1, Z S Katusić.   

Abstract

BACKGROUND: The L-arginine/nitric oxide pathway plays a key role in the regulation of arterial tone. Biosynthesis of nitric oxide requires activation of nitric oxide synthase in the presence of tetrahydrobiopterin as a cofactor. Biochemical studies demonstrated that activation of purified nitric oxide synthase at suboptimal concentrations of tetrahydrobiopterin leads to production of hydrogen peroxide. The present experiments were designed to determine whether in coronary arteries inhibition of tetrahydrobiopterin synthesis may favor nitric oxide synthase-catalyzed production of hydrogen peroxide. METHODS AND
RESULTS: Primary branches of canine left anterior descending artery were incubated for 6 hours in minimum essential medium in the presence or in the absence of the tetrahydrobiopterin synthesis inhibitor 2,4-diamino-6-hydroxypyrimidine (DAHP; 10(-2) mol/L). Arterial rings were suspended for isometric tension recording. Production of cGMP was measured by radioimmunoassay. Experiments were performed in the presence of indomethacin (10(-5) mol/L). During contractions to the thromboxane A2/prostaglandin H2 receptor agonist U46619 (10(-7) mol/L), calcium ionophore A23187 (10(-9) to 10(-6) mol/L) caused endothelium-dependent relaxations. A nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (3 x 10(-4) mol/L), significantly inhibited these relaxations. In DAHP-treated arteries, relaxations to A23187 and its stimulating effect on cGMP production were significantly reduced in the presence of catalase (1200 U/mL). By contrast, catalase did not exert any effect in rings incubated in the absence of DAHP. Furthermore, the inhibitory effect of catalase on A23187-induced relaxations was abolished when coronary arteries were incubated in the presence of DAHP plus a liposoluble analogue of tetrahydrobiopterin, 6-methyltetrahydropterin (10(-4) mol/L).
CONCLUSIONS: The present study suggests that hydrogen peroxide may be a mediator of endothelium-dependent relaxations in coronary arteries depleted of tetrahydrobiopterin. This initially compensatory response, triggered by a dysfunctional nitric oxide synthase, may represent an important mechanism underlying oxidative vascular injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528647     DOI: 10.1161/01.cir.91.1.139

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  43 in total

1.  Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin.

Authors:  J Jiang; G Valen; S Tokuno; P Thorén; J Pernow
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Free radical production by dysfunctional eNOS.

Authors:  M C Verhaar; P E Westerweel; A J van Zonneveld; T J Rabelink
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 3.  Oxidative stress in diabetic nephropathy.

Authors:  N Kashihara; Y Haruna; V K Kondeti; Y S Kanwar
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 4.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

5.  Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization.

Authors:  B M List; B Klösch; C Völker; A C Gorren; W C Sessa; E R Werner; W R Kukovetz; K Schmidt; B Mayer
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

6.  Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

Authors:  E Stroes; J Kastelein; F Cosentino; W Erkelens; R Wever; H Koomans; T Lüscher; T Rabelink
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

7.  Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 mice.

Authors:  Livius V dʼUscio; Anantha V R Santhanam; Zvonimir S Katusic
Journal:  J Cardiovasc Pharmacol       Date:  2014-12       Impact factor: 3.105

Review 8.  The L-arginine-nitric oxide pathway in hypertension.

Authors:  Malte Kelm
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 9.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

Review 10.  Nitric oxide insufficiency and atherothrombosis.

Authors:  Barbara Voetsch; Richard C Jin; Joseph Loscalzo
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.